Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene Therapy
Human Gene Therapy Clinical Development · 2017-12 · 28 (4) · 187-196
DOI: 10.1089/humc.2017.109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy Clinical Development, 2017-12. Verfasst von Haiyan Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1 Center for Gene Therapy, Research Institute at Nationwide Children's Hospital , Columbus, Ohio. Hauptthemen laut MEDLINE: Genetic Therapy. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCI NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1 Center for Gene Therapy, Research Institute at Nationwide Children's Hospital , Columbus, Ohio.
- 4 Department of Pediatrics, School of Medicine The Ohio State University , Columbus, Ohio.
- 3 Division of Molecular and Human Genetics, Research Institute at Nationwide Children's Hospital , Columbus, Ohio.
- 2 Center for Cardiovascular Research, Research Institute at Nationwide Children's Hospital , Columbus, Ohio.
- 5 Department of Neurology, School of Medicine The Ohio State University , Columbus, Ohio.
Förderung
- NINDS NIH HHS
- NCI NIH HHS
Zitieren
APA
Fu, H., Meadows, A. S., Pineda, R. J., Kunkler, K. L., Truxal, K. V., McBride, K. L., Flanigan, K. M., & McCarty, D. M. (2017). Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene Therapy. Human Gene Therapy Clinical Development, 28(4), 187-196. https://doi.org/10.1089/humc.2017.109
Vancouver
Fu H, Meadows AS, Pineda RJ, Kunkler KL, Truxal KV, McBride KL, et al. Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene Therapy. Human Gene Therapy Clinical Development. 2017;28(4):187-196. doi:10.1089/humc.2017.109
BibTeX
@article{Fu2017,
author = {Fu, Haiyan and Meadows, Aaron S and Pineda, Ricardo J and Kunkler, Krista L and Truxal, Kristen V and McBride, Kim L and Flanigan, Kevin M and McCarty, Douglas M},
title = {Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene Therapy},
journal = {Human Gene Therapy Clinical Development},
year = {2017},
volume = {28},
number = {4},
pages = {187--196},
doi = {10.1089/humc.2017.109}
}
EUVIMED